Julian Quigley

Author's details

Name: Julian Quigley
Date registered: 05/07/2012

Latest posts

  1. Space is the place…to experiment — 11/08/2017
  2. How do you give coffee authentication an extra shot? — 08/05/2017
  3. Nitrate in infants’ vegetable food — 15/03/2017
  4. Are your assay values below specification? — 13/03/2017
  5. Celebrating 25 years of Food Microbiology Proficiency Testing — 02/03/2017

Most commented posts

  1. Metabolism of therapeutic peptides — 1 comment

Author's posts listings

Nov 17

New strict codes of practice for mitigating acrylamide formation

In September 2016, the E.U. Commission presented an amended regulation proposal for acrylamide, based on feedback from the stakeholders’ consultation. The Regulation is proposed to be made under Article 4 of Regulation (EC) No. 852/2004 on the hygiene of foodstuffs, and it sets out a requirement for food business operators to take account of strict …

Continue reading »

Jul 29

Three peaks challenge update

This year we’re raising funds for our corporate charity, MND (Motor Neurone Disease) Association, whose vision is a world free from MND. While not quite the ice bucket challenge seen in the news this week, in one week’s time some of our team at LGC will be completing their own fundraising event. Fourteen of LGC’S …

Continue reading »

Jul 25

Fromelles: The spirit lives

The Battle of Fromelles commenced on 19 July 1916, 19 days after the opening of the Somme campaign on the Western Front. It is a day and a place that is marked by a tragic sacrifice as this day is the bloodiest day of battle in  Australia’s military history. The 5th Australian Division had arrived in …

Continue reading »

Jul 08

Management team put best foot forward for charity

On 6 and 7 August, 14 members of LGC’s Forensics & Security leadership team are undertaking the Three Peaks Challenge to raise money for The Motor Neurone Disease Association, this year’s chosen corporate charity. The Three Peaks Challenge involves climbing the three highest peaks in England, Wales and Scotland, often within 24 hours. Jon Yeung, …

Continue reading »

Apr 14

LGC can help develop new medications

This week saw World Parkinson’s Day and Dr Christian Zeine from our Standards team has been sharing his thoughts on how we are able to help develop new medications to treat this chronic and progressive disorder. “With current medical knowledge, Parkinson’s can be treated effectively, but there is no final cure at this stage. Well known …

Continue reading »

Feb 12

Quality, controlled, science for a safer world

Reference materials are essential for the scientific community to perform vital research, enabling validation of a material’s quality, analytical measurement methods or for the precise calibration of instruments. Of course, by their nature, some authentic and highly characterised materials are potentially hazardous to customers, but their sale and distribution takes place within a number of …

Continue reading »

Feb 05

Which legal highs will soon become illegal highs?

Legal highs – also known as New Psychoactive Substances (NPS) – are a constant concern. Whether it’s prison officers falling ill after inhaling legal highs used by inmates or high-profile sports stars believed to have had chemical reactions after apparently taking them, it seems they are always in the news. But what are legal highs? …

Continue reading »

Jun 26

Food safety and quality – how fresh is your fish?

The moment a fish is caught it begins the natural process of decay, being broken down by enzymes (from the fish itself or bacteria naturally present). Measuring the resulting chemicals produced gives a measure of the freshness, and thus the quality, of the fish. Similarly, as LGC’s Michael Walker asks in a recent article for Food Science …

Continue reading »

May 01

Metabolism of therapeutic peptides

Peptide and protein based drugs are significantly more complicated to work with than small molecules, and as yet do not have specific guidelines for their development with regards to in-vivo metabolites. The analysis of metabolites from small molecule drugs is defined by the FDA in the metabolites in safety testing guidelines (MIST, 2008). Currently, analytical …

Continue reading »

Mar 20

Ultrasensitive immunoassays using single molecule counting technology

Traditional ELISA-based immunoassays have struggled to determine baseline endogenous concentrations for many biomarkers. The Erenna® Immunoassay System is based on the same principles as a plate-based sandwich ELISA but offers 50-1000 fold greater sensitivity through a combination of microparticle bead (MB) capture and single molecule counting of fluorescently labelled detection molecules. MB’s have the dual …

Continue reading »

Older posts «

» Newer posts

%d bloggers like this: